Man who Picked Bitcoin at $428 Says "Buy Genesis"
He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...

NASDAQ:CGNX - Cognex Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $82.00
  • Forecasted Upside: 2.56 %
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$79.95
▲ +0.25 (0.31%)
1 month | 3 months | 12 months
Get New Cognex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGNX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGNX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$82.00
▲ +2.56% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Cognex in the last 3 months. The average price target is $82.00, with a high forecast of $120.00 and a low forecast of $47.00. The average price target represents a 2.56% upside from the last price of $79.95.
Could This Be the Biggest US Gold Discovery in Years?
See how this tiny, unknown gold company secured a prime land package right next door to the world’s two largest gold producers in Nevada’s famed Carlin Trend where 84 Million gold ounces have already been extracted. Best of all, investors can still get in well below US$0.50 per share.
pixel

Hold

The current consensus among 8 investment analysts is to hold stock in Cognex. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 2 sell ratings
12/21/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 2 sell ratings
3/20/2020
  • 1 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 3 sell ratings
6/18/2020
  • 1 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 3 sell ratings
9/16/2020
  • 1 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 3 sell ratings
12/15/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
3/15/2021
  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
5/14/2021
  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
6/13/2021

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/19/2021Raymond JamesUpgradeOutperform ➝ Strong-Buy$100.00 ➝ $120.00Medium
i
5/7/2021Morgan StanleyBoost Price TargetUnderweight$68.00 ➝ $72.00Low
i
2/12/2021CowenBoost Price TargetOutperform$85.00 ➝ $105.00Low
i
2/12/2021Raymond JamesBoost Price TargetOutperform$75.00 ➝ $100.00Low
i
2/12/2021Morgan StanleyBoost Price TargetUnderweight$62.00 ➝ $68.00Low
i
1/20/2021Morgan StanleyBoost Price TargetUnderweight$57.00 ➝ $62.00Low
i
1/14/2021HSBCUpgradeHold ➝ BuyMedium
i
10/29/2020Morgan StanleyBoost Price TargetUnderweight$55.00 ➝ $57.00High
i
10/29/2020Robert W. BairdUpgradeUnderperform ➝ Neutral$63.00High
i
Rating by Richard Eastman at Robert W. Baird
10/16/2020StephensInitiated CoverageOverweight$85.00Medium
i
9/4/2020Daiwa Capital MarketsDowngradeOutperform ➝ NeutralHigh
i
8/25/2020Wolfe ResearchInitiated CoverageUnderperform$47.00Medium
i
7/31/2020Morgan StanleyBoost Price TargetUnderweight$39.00 ➝ $55.00Medium
i
6/2/2020Robert W. BairdDowngradeNeutral ➝ Underperform$44.00 ➝ $45.00High
i
5/25/2020HSBCInitiated CoverageHold$55.00Medium
i
5/8/2020UBS GroupBoost Price TargetNeutral$43.00 ➝ $56.00Low
i
Rating by Markus Mittermaier at UBS Group AG
4/28/2020Robert W. BairdBoost Price TargetNeutral$39.00 ➝ $44.00Medium
i
4/28/2020Morgan StanleyBoost Price TargetUnderweight$36.00 ➝ $39.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
4/28/2020Raymond JamesBoost Price TargetOutperform$48.00 ➝ $60.00High
i
4/17/2020JPMorgan Chase & Co.Boost Price TargetUnderweight$36.00 ➝ $40.00Low
i
3/23/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$42.00 ➝ $36.00High
i
Rating by Joshua Pokrzywinski at Morgan Stanley
3/17/2020Morgan StanleyLower Price TargetEqual Weight$49.00 ➝ $42.00High
i
Rating by Joshua Pokrzywinski at Morgan Stanley
2/19/2020Morgan StanleyBoost Price TargetEqual Weight$47.00 ➝ $49.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
12/12/2019UBS GroupInitiated CoverageNeutral$52.00High
i
11/1/2019Morgan StanleySet Price TargetHold$47.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/29/2019Needham & Company LLCReiterated RatingHoldLow
i
9/24/2019Daiwa Capital MarketsSet Price TargetHold$53.00Low
i
Rating by Jairam Nathan at Daiwa Capital Markets
9/23/2019DA DavidsonBoost Price TargetNeutral$40.00 ➝ $45.00Low
i
9/23/2019Robert W. BairdBoost Price TargetNeutral$42.00 ➝ $47.00Low
i
9/23/2019CowenReiterated RatingOutperform$50.00 ➝ $60.00Low
i
7/16/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell$45.00 ➝ $36.00High
i
7/10/2019Morgan StanleyLower Price TargetEqual Weight$47.00 ➝ $43.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
5/3/2019Morgan StanleySet Price TargetHold$47.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
4/30/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
i
4/30/2019Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$46.00High
i
4/17/2019Gordon HaskettInitiated CoverageHold ➝ Hold$54.00Low
i
2/12/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$47.00 ➝ $50.00High
i
12/13/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$45.00 ➝ $47.00High
i
11/19/2018Berenberg BankInitiated CoverageBuy ➝ Buy$54.00High
i
11/1/2018Daiwa Capital MarketsSet Price TargetBuy$49.00Low
i
Rating by Jairam Nathan at Daiwa Capital Markets
10/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$52.00 ➝ $40.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/30/2018Needham & Company LLCLower Price TargetBuy ➝ Buy$52.00 ➝ $45.00High
i
10/16/2018Needham & Company LLCUpgradeHold ➝ Buy$52.00High
i
10/11/2018Morgan StanleySet Price TargetHold$57.00 ➝ $52.00High
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/2/2018DA DavidsonInitiated CoverageNeutral$57.00Low
i
Rating by M. Summerville at DA Davidson
8/24/2018Northcoast ResearchDowngradeBuy ➝ Neutral$54.00Medium
i
Rating by Tom Hayes at Northcoast Research
8/20/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.00Medium
i
8/1/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$40.10High
i
7/31/2018Northcoast ResearchSet Price TargetBuy$56.00High
i
Rating by Tom Hayes at Northcoast Research
7/31/2018Robert W. BairdReiterated RatingHold$48.00High
i
5/7/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$42.00Low
i
Rating by Paul Coster at JPMorgan Chase & Co.
5/1/2018Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
i
5/1/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$62.00 ➝ $40.00High
i
5/1/2018JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Hold$62.50 ➝ $42.00High
i
Rating by Paul Coster at JPMorgan Chase & Co.
4/10/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$78.00 ➝ $55.00High
i
Rating by Joe Ritchie at The Goldman Sachs Group, Inc.
4/4/2018Northcoast ResearchUpgradeNeutral ➝ BuyHigh
i
Rating by T. Hayes at Northcoast Research
4/3/2018JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$63.00Low
i
Rating by Paul Coster at JPMorgan Chase & Co.
1/19/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy ➝ Buy$80.00Low
i
11/8/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$62.50N/A
i
10/31/2017Canaccord GenuityBoost Price TargetHold$47.50 ➝ $60.00N/A
i
10/31/2017Robert W. BairdBoost Price TargetNeutral$50.00 ➝ $62.00N/A
i
8/14/2017Wolfe ResearchUpgradeMarket Perform ➝ OutperformLow
i
8/8/2017CowenReiterated RatingOutperform$50.00 ➝ $67.50Low
i
8/2/2017CowenBoost Price TargetOutperform$50.00 ➝ $67.50Low
i
7/11/2017Wolfe ResearchInitiated CoveragePeer PerformMedium
i
7/11/2017CowenReiterated RatingBuy$50.00Medium
i
5/3/2017Canaccord GenuityReiterated RatingHold$32.50 ➝ $40.00Low
i
5/2/2017CowenLower Price TargetOutperform$50.00 ➝ $45.00Low
i
4/3/2017The Goldman Sachs GroupInitiated CoverageBuy ➝ BuyMedium
i
3/30/2017Summit RedstoneReiterated RatingBuyMedium
i
Rating by J. Iyer at Summit Redstone
3/21/2017Needham & Company LLCReiterated RatingHoldHigh
i
3/15/2017Needham & Company LLCDowngradeBuy ➝ HoldLow
i
2/17/2017Needham & Company LLCReiterated RatingBuy$30.50 ➝ $40.00N/A
i
1/26/2017JPMorgan Chase & Co.Initiated CoverageNeutral$33.00N/A
i
12/8/2016Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00N/A
i
12/2/2016Northcoast ResearchDowngradeBuy ➝ Neutral$29.50N/A
i
Rating by T. Hayes at Northcoast Research
11/2/2016Canaccord GenuityReiterated RatingHoldN/A
i
Rating by robert burleson at Canaccord Genuity
11/1/2016Needham & Company LLCBoost Price TargetBuy$27.50 ➝ $30.50N/A
i
10/25/2016StephensInitiated CoverageEqual Weight$25.00N/A
i
9/20/2016Canaccord GenuitySet Price TargetHold$24.50N/A
i
Rating by robert burleson at Canaccord Genuity
8/2/2016Canaccord GenuityBoost Price TargetHold$22.50 ➝ $24.50N/A
i
Rating by Robert Burleson at Canaccord Genuity
8/2/2016Needham & Company LLCBoost Price TargetBuy$21.00 ➝ $27.50N/A
i
Rating by James Ricchiuti at Needham & Company LLC
6/14/2016Canaccord GenuityDowngradeBuy ➝ Hold$22.50N/A
i
Rating by Robert Burleson at Canaccord Genuity
(Data available from 6/14/2016 forward)
Cognex logo
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; Cognex Designer that allows customers to build vision applications with a graphical, flowchart-based programming environment; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; and vision sensors for vision applications, such as checking the presence and size of parts; the In-Sight product line of vision systems and sensors. In addition, the company offers ID products comprising DataMan image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. The company was founded in 1981 and is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $79.95
$79.30
$80.28

50 Day Range

MA: $80.83
$73.17
$88.20

52 Week Range

Now: $79.95
$53.65
$101.82

Volume

428,900 shs

Average Volume

783,038 shs

Market Capitalization

$14.12 billion

P/E Ratio

63.45

Dividend Yield

0.30%

Beta

1.64

Frequently Asked Questions

What sell-side analysts currently cover shares of Cognex?

The following Wall Street analysts have issued reports on Cognex in the last year: Cowen Inc, Daiwa Capital Markets, HSBC Holdings plc, Morgan Stanley, Raymond James, Robert W. Baird, Stephens, TheStreet, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for CGNX.

What is the current price target for Cognex?

6 Wall Street analysts have set twelve-month price targets for Cognex in the last year. Their average twelve-month price target is $82.00, suggesting a possible upside of 2.6%. Raymond James has the highest price target set, predicting CGNX will reach $120.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $47.00 for Cognex in the next year.
View the latest price targets for CGNX.

What is the current consensus analyst rating for Cognex?

Cognex currently has 2 sell ratings, 2 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CGNX, but not buy more shares or sell existing shares.
View the latest ratings for CGNX.

What other companies compete with Cognex?

How do I contact Cognex's investor relations team?

Cognex's physical mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company's listed phone number is 508-650-3000 and its investor relations email address is [email protected] The official website for Cognex is www.cognex.com.

Six Tech Stocks That Could Double
5G… blockchain… electric vehicles… There are enough tech opportunities out there to make your head spin! But which ones should you own for the coming tech boom?

Louis Navellier — the analyst who found Microsoft at .38 cents — just released a new report detailing six tech stocks to own today.

Don’t miss your chance to get his latest picks — ticker symbol and all — completely free of charge.
pixel